Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

BioNTech Q3 EPS $(0.14) Misses $0.75 Estimate, Sales $1.776B Beat $1.190B Estimate

Author: Benzinga Newsdesk | November 03, 2025 06:48am
BioNTech (NASDAQ:BNTX) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $0.75 by 118.67 percent. This is a 115.73 percent decrease over earnings of $0.89 per share from the same period last year. The company reported quarterly sales of $1.776 billion which beat the analyst consensus estimate of $1.190 billion by 49.24 percent. This is a 29.82 percent increase over sales of $1.368 billion the same period last year.

Posted In: BNTX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist